Eduard Jirkovský

6PUBLICATIONS
37CO-AUTHORS
Molecular medicineGenetically modified animalsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 18, 2024
The quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (KV) channels.

Patrícia Dias, Rudy Salam, Jana Pourová

|Apr 08, 2022
The effects of bisphenols on the cardiovascular system.

Patrícia Dias, Václav Tvrdý, Eduard Jirkovský

|Sep 23, 2021
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation.

Eduard Jirkovský, Anna Jirkovská, Hana Bavlovič-Piskáčková

|Feb 15, 2021
Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin.

Václav Tvrdý, Jana Pourová, Eduard Jirkovský

|Sep 30, 2020
Clearance of senescent cells during cardiac ischemia-reperfusion injury improves recovery.

Emily Dookun, Anna Walaszczyk, Rachael Redgrave

|Apr 08, 2020
Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity.

Petra Kollárová-Brázdová, Anna Jirkovská, Galina Karabanovich

Pageof 1

Frequent Collaborators

3 joint publications

Petra Štěrbová-Kovaříková

3 joint publications

Přemysl Mladěnka

2 joint publications

Anna Jirkovská

2 joint publications

Galina Karabanovich